
Sign up to save your podcasts
Or


Apple falls after CEO Tim Cook lowers revenue guidance for the 1st quarter. Bristol-Myers Squibb gives Celgene shareholders $74 billion reasons to smile. MFAM Funds portfolio manager Bill Barker analyzes the latest headlines and what it means for investors. Plus, we dip into the Fool Mailbag to discuss investing for your (adult) children. (Tangents include company rebranding fails, Harry Potter’s effect on today’s mega-merger, and why Bill hasn’t been in the studio in awhile.)
By The Motley Fool4.7
16041,604 ratings
Apple falls after CEO Tim Cook lowers revenue guidance for the 1st quarter. Bristol-Myers Squibb gives Celgene shareholders $74 billion reasons to smile. MFAM Funds portfolio manager Bill Barker analyzes the latest headlines and what it means for investors. Plus, we dip into the Fool Mailbag to discuss investing for your (adult) children. (Tangents include company rebranding fails, Harry Potter’s effect on today’s mega-merger, and why Bill hasn’t been in the studio in awhile.)

3,215 Listeners

1,490 Listeners

807 Listeners

945 Listeners

523 Listeners

1,166 Listeners

2,184 Listeners

825 Listeners

1,423 Listeners

1,036 Listeners

9,715 Listeners

196 Listeners

826 Listeners

85 Listeners

590 Listeners

1,026 Listeners

53 Listeners